CTA
ABBV icon

Colonial Trust Advisors’s AbbVie ABBV Stock Holding History

Colonial Trust Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$781K Buy
3,104
+318
+11% +$68.4K 0.05% 130
2026
Q1 		$606K Sell
2,786
-106
-4% -$23.5K 0.05% 136
2025
Q4 		$661K Buy
2,892
+83
+3% +$18.9K 0.05% 137
2025
Q3 		$650K Sell
2,809
-138
-5% -$28.1K 0.05% 140
2025
Q2 		$547K Buy
2,947
+220
+8% +$40.9K 0.05% 141
2025
Q1 		$571K Buy
2,727
+137
+5% +$26.6K 0.05% 136
2024
Q4 		$460K Sell
2,590
-143
-5% -$26.3K 0.04% 146
2024
Q3 		$540K Buy
2,733
+6
+0.2% +$1.12K 0.05% 142
2024
Q2 		$468K Sell
2,727
-192
-7% -$31.8K 0.04% 131
2024
Q1 		$532K Buy
2,919
+75
+3% +$12.9K 0.05% 130
2023
Q4 		$441K Hold
2,844
– – 0.05% 140
2023
Q3 		$424K Sell
2,844
-4
-0.1% -$587 0.05% 142
2023
Q2 		$384K Hold
2,848
– – 0.04% 152
2023
Q1 		$454K Sell
2,848
-9
-0.3% -$1.38K 0.05% 144
2022
Q4 		$462K Hold
2,857
– – 0.06% 143
2022
Q3 		$383K Buy
2,857
+760
+36% +$109K 0.05% 146
2022
Q2 		$321K Hold
2,097
– – 0.05% 140
2022
Q1 		$340K Buy
2,097
+28
+1% +$4.07K 0.04% 151
2021
Q4 		$280K Hold
2,069
– – 0.03% 162
2021
Q3 		$223K Hold
2,069
– – 0.03% 176
2021
Q2 		$233K Sell
2,069
-100
-5% -$11.3K 0.03% 178
2021
Q1 		$235K Sell
2,169
-7
-0.3% -$749 0.03% 172
2020
Q4 		$233K Buy
+2,176
New +$209K 0.03% 158

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Colonial Trust Advisors's ABBV Position: Q2 2026 in Review

Colonial Trust Advisors increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $68.4K and bringing the position to 3,104 shares worth $781K. The position accounts for 0.05% of the portfolio, ranked #130.

Colonial Trust Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Colonial Trust Advisors held 3,104 shares of AbbVie worth $781K as of Q2 2026.
  • Colonial Trust Advisors bought 318 AbbVie shares in Q2 2026, an estimated $68.4K.
  • AbbVie made up 0.05% of Colonial Trust Advisors's portfolio in Q2 2026, its #130 holding.
  • Colonial Trust Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.